ArticleBMC nephrology2025
Obesity and mortality in KDIGO stage 3 acute kidney injury: a machine learning-driven retrospective cohort study.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advanced lung cancer inflammation index is associated with mortality in critically ill patients with acute kidney injury.Clinics (Sao Paulo, Brazil) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute kidney injury (AKI) is a common and life-threatening condition in intensive care unit (ICU) patients. The relationship between body mass index (BMI) and survival outcomes in the Kidney Disease: Improving Global Outcomes (KDIGO) stage 3 AKI remains unclear. Clarifying this association is essential for risk stratification and optimizing individualized management in critically ill populations.
methodsA retrospective cohort study was conducted using the Medical Information Mart for Intensive Care IV (MIMIC-IV) 3.0 database, including 5609 ICU patients with KDIGO stage 3 AKI. Patients were categorized according to the World Health Organization (WHO) BMI classification. The primary outcomes were all-cause mortality at 7, 28, and 365 days after ICU admission. Statistical analyses included restricted cubic spline (RCS) modelling, logistic regression, and Kaplan–Meier (KM) survival curves to evaluate the association between BMI and mortality. A random forest-based Boruta algorithm was applied for feature selection, and multiple machine learning models were developed to predict mortality risk, with their performances compared to identify the optimal approach.
resultsHigher BMI was inversely associated with mortality risk, with the protective effect becoming more pronounced over time. Patients with higher BMI had significantly lower 28-day and 365-day mortality (OR < 1, p < 0.05). RCS analysis confirmed a nonlinear protective relationship between BMI and mortality. However, this survival benefit was attenuated in patients who received continuous renal replacement therapy (CRRT), suggesting an interaction between BMI and CRRT on survival outcomes. Among various predictive models, the Light Gradient Boosting Machine (LightGBM) demonstrated the highest predictive accuracy.
conclusionsLightGBM demonstrated the highest predictive performance for mortality risk in ICU patients with KDIGO stage 3 AKI. Higher BMI was independently associated with improved short- and long-term survival, although this protective effect was attenuated in those receiving CRRT. These findings support incorporating BMI into risk stratification and prognostic modelling for KDIGO stage 3 AKI patients, while accounting for the modifying impact of renal replacement therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.